Jose C Clemente, Julia Manasson, Jose U Scher
BMJ 2018;360:j5145 doi: 10.1136/bmj.j5145
ABSTRACT
The role of the gut microbiome in models of inflammatory and autoimmune disease
is now well characterized. Renewed interest in the human microbiome and its
metabolites, as well as notable advances in host mucosal immunology, has opened
multiple avenues of research to potentially modulate inflammatory responses. The
complexity and interdependence of these diet-microbe-metabolite-host interactions
are rapidly being unraveled. Importantly, most of the progress in the field comes
from new knowledge about the functional properties of these microorganisms in
physiology and their effect in mucosal immunity and distal inflammation. This review
summarizes the preclinical and clinical evidence on how dietary, probiotic, prebiotic,
and microbiome based therapeutics affect our understanding of wellness and
disease, particularly in autoimmunity.
Other Top5 Articles
Exercise, orthoses and splinting for treating Achilles tendinopathy: a systematic review with meta-analysis
Fiona Wilson et al
Br J Sports Med 2018;52:1564–1574
Fascial tissue research in sports medicine: from molecules to tissue adaptation, injury and diagnostics: consensus statement
Zugel et al
Br J Sports Med 2018;52:1497
2019 Canadian guideline for physical activity throughout pregnancy
Mottola et al
Journal of Obstetrics and Gynaecology Canada. 2018;40(11):1549–1559
Conservative management of lateral hip pain: the future holds promise
Alison Grimaldi
British Journal of Sports Medicine, Br J Sports Med 2017;51:72-73 doi:10.1136/bjsports-2016-096600
© 2020 Sportscare • Phone 09 267 3335 • Email us • Clinic • Design by Husk